miRview® lung is a new kind of test. Your doctor can use it to tell if you have SCLC, carcinoid, squamous NSCLC or non-squamous NSCLC.

miRview® lung is different from other tests. It is more accurate because it uses cutting-edge technology to measure tiny amounts of material in your tumor sample¹. The material it measures is called microRNA. microRNAs are short RNA molecules that regulate gene expression in our cells. Once your sample has been tested, a clear, easy-to-understand report will be generated. Your doctor will receive this report about 10 days after he or she sends in your sample for processing. The report will tell your doctor whether you have SCLC, carcinoid, squamous NSCLC or non-squamous NSCLC.

miRview® lung uses highly sensitive technology to measure the level of microRNAs in your sample. The sensitivity and specificity of this test have been shown to be 93.7% and 98%, respectively².

1. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin.
   Nat Biotechnol. 2008;26(4):462-469.
2. Data on file, Rosetta Genomics.